Being diagnosed with high blood pressure is important, as it is one of the biggest risk factors for heart attacks and strokes ...

Health department investigates deaths of two dialysis patients at Haripad hospital, closing the unit for 15 days for evaluation.

At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for ...

The approval of subcutaneous amivantamab allows physicians flexibility in offering treatment for non–small cell lung cancer.

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to ...

The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...

HAI Solutions, a leading innovator in ultraviolet (UVC) microbial reduction medical devices, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo classification for its ...

HAI Solutions receives US FDA De Novo grant for QIKCAP System: Pioneering UVC technology for microbial reduction on needleless IV connectors: Carlsbad, California Friday, January ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

The recent wave of pharmaceutical tragedies in Sri Lanka, as well as some others that have occurred regularly in the past, ...

Belgium: Johnson & Johnson has announced that the European Commission has extended the marketing authorisation for TREMFYA ...

Key challenges include logistical hurdles, such as the need for specialized training and infrastructure, and financial ...